{"id":205089,"name":"TIBER CREEK GROUP (ON BEHALF OF BRISTOL MYERS SQUIBB)","slug":"tiber-creek-group-on-behalf-of-bristol-myers-squibb","state":"DC","country":"United States of America","description":"Global biopharmaceutical company.","totalSpending":480000,"filings":22,"yearlySpending":[{"year":2020,"income":40000},{"year":2021,"income":140000},{"year":2022,"income":120000},{"year":2023,"income":100000},{"year":2024,"income":80000},{"year":2025,"income":0}],"issues":["HCR","MMM"],"firms":["TIBER CREEK HEALTH STRATEGIES, INC."],"lobbyists":["JAMES HALL"],"govEntities":["SENATE"],"sampleDescriptions":["Issues related to drug pricing.","Issues related to drug pricing.","HR 6201  Families First Coronavirus Response Act (PL 116-27) - drug pricing  issues. CARES Act - S. 3548 (PL 116-136) - drug pricing issues","CARES Act - S. 3548 (PL 116-136) - drug pricing issues. H.R. 6800 the Health and Economic Recovery Omnibus Emergency Solutions Act","Issues related to drug pricing"],"years":[2020,2021,2022,2023,2024,2025]}